Vanderbilt University Medical Center: Hypertension trials

The registry lists 22 Hypertension studies with Vanderbilt University Medical Center as lead sponsor. 9 are open to participants now and 9 have results posted.

Phase 1 3Phase 2 6Phase 4 2No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in HumansNot yet recruitingNCT07602166Phase 2
• 2-HOBA in Systemic Lupus ErythematosusRecruitingNCT07225543Phase 2
• Evaluating the Effectiveness of a Multi-level Health-Related Social Needs InitiativeEnrolling by invitationNCT06831162Not applicable
• Exercise Testing After PreeclampsiaRecruitingNCT06741436
• CPAP for the Treatment of Supine HypertensionRecruitingNCT05489575Not applicable
• Sympathetic Mechanisms in Obesity-Crossover DesignRecruitingNCT05312892Phase 1/2
• Gut Microbiota in Metabolic SurgeryRecruitingNCT05000996
• Treatment of Supine Hypertension in Autonomic Failure (CPAP)RecruitingNCT03312556Not applicable
• Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionRecruitingNCT03042988Not applicable
• Comprehensive Postpartum Management for Women With Hypertensive Disorders of PregnancyCompletedNCT05849103Not applicableResults posted
• CARDIA-Salt Sensitivity of Blood Pressure (SSBP)CompletedNCT04258332Not applicableResults posted
• Nashville - Hypertension Management ModelCompletedNCT04232124Not applicableResults posted
• Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1TerminatedNCT03738878Phase 4Results posted
• Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular DiseaseTerminatedNCT03709771Results posted
• Tamoxifen Therapy to Treat Pulmonary Arterial HypertensionCompletedNCT03528902Phase 2Results posted
• The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial FunctionCompletedNCT03115853Phase 4Results posted
• A Mobile Health Intervention in Pulmonary Arterial HypertensionCompletedNCT03069716Not applicableResults posted
• Treatment of Resistant Hypertension by Prevention of T-Cell Co-StimulationTerminatedNCT02232880Phase 2Results posted
• Family at Risk StudyWithdrawnNCT04607876Not applicable
• Salt-Sensitivity and Immunity Cell ActivationActive, not recruitingNCT03753204Phase 1/2
• Right Ventricular Metabolism in Pulmonary Arterial HypertensionCompletedNCT02763735
• Pathophysiology of Cardiometabolic Risk Factors in African AmericansCompletedNCT01122407Phase 1